A single institution analysis of low-dose-rate brachytherapy: 5-year reported survival and late toxicity outcomes

PURPOSE: To report the 5-year biochemical relapse-free survival (BRFS), overall survival (OS), and long-term toxicity outcomes of patients treated with low-dose-rate (LDR) brachytherapy as monotherapy for low- to intermediate-risk prostate cancer. MATERIAL AND METHODS: Between 2004 and 2011, 371 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Michael, Spencer, Sandra, Guerrieri, Mario, Ding, Wei, Goharian, Mehran, Ho, Huong, Ng, Michael, Healey, Danielle, Tan, Alwin, Cham, Chee, Joon, Daryl Lim, Lawrentschuk, Nathan, Travis, Douglas, Sengupta, Shomik, Chan, Yee, Troy, Andrew, Pham, Trung, Clarke, David, Liodakis, Peter, Bolton, Damien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961530/
https://www.ncbi.nlm.nih.gov/pubmed/29789764
http://dx.doi.org/10.5114/jcb.2018.75600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961530/
https://www.ncbi.nlm.nih.gov/pubmed/29789764
http://dx.doi.org/10.5114/jcb.2018.75600

Ejemplares similares